Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06020703 · ClinicalTrials.gov registry record · NA

A Study of Healthy Microbiome, Healthy Mind

A NA study of COVID-19 and Cognitive Impairment, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06020703 is a NA study of COVID-19 and Cognitive Impairment that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06020703, a NA study of COVID-19 and Cognitive Impairment, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including severe COVID-19, by promoting gut health recovery and decreasing gut inflammation.

Interventions

  • BEHAVIORAL Fermented Food Diet

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-26
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06020703

The ClinicalTrials.gov registry entry for NCT06020703 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Fermented Food Diet is the first listed.

NCT06020703 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06020703 about?

NCT06020703 is a clinical study titled "A Study of Healthy Microbiome, Healthy Mind". Researchers are doing this study to find out if a high fermented food diet is tolerable, and if it will help improve quality of life after surviving a critical illness, including severe COVID-19, by promoting gut health recovery and decreasing gut inflammation.

What is the current status of trial NCT06020703?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-26. Estimated completion is 2026-12.

What conditions does trial NCT06020703 study?

This clinical trial studies the following conditions: COVID-19, Cognitive Impairment, Critical Illness, Dysbiosis, Weakness, Muscle.

What interventions are being tested in trial NCT06020703?

The interventions under investigation include: Fermented Food Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT06020703?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06020703 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.